Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 6 Breast Neoplasms 5 Prostatic Neoplasms 4 Hematologic Neoplasms 4 Colorectal Neoplasms 4 Melanoma 3 Lung Neoplasms 3 Pancreatic Neoplasms 2 Malignant Solid Neoplasm 2 Leukemia, Myeloid, Acute 2 Hematopoietic and Lymphatic System Neoplasm 2 Head and Neck Neoplasms 2 COVID-19 2 Urologic Neoplasms 1 Urologic Diseases 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spondylitis, Ankylosing 1 Speech 1 Seroma 1 Rectal Neoplasms 1 Psoriasis 1 Progressive Metastatic Castrate Resistant Prostate Cancer 1 Postoperative Complications 1 Peritoneal Neoplasms 1 Parotid Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1

Interventions

Paclitaxel 2 Laparoscopy 2 nilotinib 1 liposomal doxorubicin 1 Topotecan 1 Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Electrocardiography 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × Standard of Care × 30 days × Clear all

NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡